IMS Health’s Yan Shangjun On China’s Changing Diabetes Market: An Interview With PharmAsia News
This article was originally published in PharmAsia News
Executive Summary
IMS Health Inc. Pharma Insight Principal Yan Shangjun sits down with PharmAsia News to talk about the evolution of China’s diabetes market and how opinions of Chinese doctors affect the market.